Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Valent U S A LLC has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners within 1 distinct art unit, showing separate examiner assignments in a shared examination setting. This structure supports coordination of recurring technical positions at the art-unit level, while each application still requires its own response analysis.
MEYERS, ELIZABETH ANNE is the busiest examiner, with 1 pending matter. That examiner handles part of the identified action load, while another examiner handles the remaining activity. Counsel should track the assignments separately and tailor biotechnology or pharmaceutical arguments to the particular objections in each application.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERS, ELIZABETH ANNE | 1 | 22.2% | +93.3% |
| PIPIC, ALMA | 1 | 54.8% | +54.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18463497 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | MEYERS, ELIZABETH ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17137985 | BACILLUS AMYLOLIQUEFACIENS AND NEONICOTINOIDS MIXTURES AND METHODS OF USE THEREOF | PIPIC, ALMA | 89d overdue |
| 18463497 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | MEYERS, ELIZABETH ANNE | — |
| Art Unit | Apps |
|---|---|
| 1617 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18463497 | HERBICIDAL COMPOSITIONS AND METHODS OF USE THEREOF | MEYERS, ELIZABETH ANNE | 1617 | §103DP | Non-Final OA | — | Pending | Sep 08, 2023 |
| 17137985 | BACILLUS AMYLOLIQUEFACIENS AND NEONICOTINOIDS MIXTURES AND METHODS OF USE THEREOF | PIPIC, ALMA | 1617 | §103 | Final Rejection | 89d overdue | Pending | Dec 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialValent U S A LLC has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Elizabeth Anne Meyers has the most, with 1 of Valent U S A LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
